Hollandia -
holland -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
equasym xl 20 mg capsule met gereguleerde afgifte, hard
shire pharmaceuticals ireland limited - methylfenidaathydrochloride samenstelling overeenkomend met; methylfenidaat; - capsule met gereguleerde afgifte, hard - methylphenidate
Hollandia -
holland -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
equasym xl 20 mg capsule met gereguleerde afgifte, hard
dr. fisher farma b.v. - methylfenidaathydrochloride samenstelling overeenkomend met; methylfenidaat; - capsule met gereguleerde afgifte, hard - methylphenidate
Hollandia -
holland -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
equasym xl 30 mg capsule met gereguleerde afgifte, hard
shire pharmaceuticals ireland limited - methylfenidaathydrochloride samenstelling overeenkomend met; methylfenidaat; - capsule met gereguleerde afgifte, hard - methylphenidate
Hollandia -
holland -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
equasym xl 40 mg, capsule met gereguleerde afgifte, hard
shire pharmaceuticals ireland limited - methylfenidaathydrochloride samenstelling overeenkomend met; methylfenidaat; - capsule met gereguleerde afgifte, hard - methylphenidate
Hollandia -
holland -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
equasym xl 50 mg, capsule met gereguleerde afgifte, hard
shire pharmaceuticals ireland limited - methylfenidaathydrochloride samenstelling overeenkomend met; methylfenidaat; - capsule met gereguleerde afgifte, hard - methylphenidate
Hollandia -
holland -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
equasym xl 60 mg, capsule met gereguleerde afgifte, hard
shire pharmaceuticals ireland limited - methylfenidaathydrochloride samenstelling overeenkomend met; methylfenidaat; - capsule met gereguleerde afgifte, hard - methylphenidate
Európai Unió -
holland -
EMA (European Medicines Agency)
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccins - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. het gebruik van dit vaccin moet gebeuren in overeenstemming met officiële aanbevelingen.
Hollandia -
holland -
Adama
kontakt® 320 sc
adama - suspensie concentraat (sc) - fenmedifam - herbicide
